Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe Locations entry changed from Napoli, Italy, 80147 to Naples, Italy, 80147.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a new resource entry for the Genetic and Rare Diseases Information Center under Resources. Updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedThe Study Results section now shows 'Results Submitted' instead of 'No Results Posted'. This indicates that results have been submitted for the trial.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision is updated from v3.4.1 to v3.4.2, with no changes to core study details or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.